Colorectal cancer (CRC) is the fourth most common cause of death from cancer in the world.
The limitations of the currently available methods and biomarkers for CRC management …

A new combined gas chromatography and mass spectrometry (GC–MS) method has been
developed suitable for the urine sample treatment in aqueous phase with ethyl …

Recent studies suggest that biofluid-based metabonomics may identify metabolite markers
promising for colorectal cancer (CRC) diagnosis. We report here a follow-up replication …

Background Rectal cancer is one of the most prevalent tumor types. Understanding the
metabolic profile of rectal cancer is important for developing therapeutic approaches and …

Colorectal cancer (CRC) is one of the leading causes of cancer-related death worldwide
and prognosis based on the conventional histological grading method for CRC remains …

Background Colorectal cancer (CRC) has been confirmed to be the third most commonly
diagnosed cancer in males and the second in females. We investigated the blood plasma …

In this study, a gas chromatography/mass spectrometry (GC/MS) method was developed
and validated for the metabolic profiling of human colon tissue. Each colon tissue sample …

Esophageal carcinoma (EC) is one of the most common malignant tumors. EC survival has
remained disappointingly low because of the high malignancy of esophageal cancer and …

Comprehensive two-dimensional gas chromatography/time-of-flight mass spectrometry
(GC× GC–TOFMS) coupled with pattern recognition methods was applied to analyze plasma …

Two-dimensional gas chromatography mass spectrometry (GCxGC-MS) is utilized to an
increasing extent in biomedical metabolomics. Here, we established and adapted …